Moens, A., van der Woude, C. J., Julsgaard, M., Humblet, E., Sheridan, J., Baumgart, D. C., Gilletta De Saint‐Joseph, C., Nancey, S., Rahier, J., Bossuyt, P., Cremer, A., Dewit, S., Eriksson, C., Hoentjen, F., Krause, T., Louis, E., Macken, E., Milenkovic, Z., Nijs, J., Posen, A., Van Hootegem, A., Van Moerkercke, W., Vermeire, S., Bar‐Gil Shitrit, A., & Ferrante, M. (2020). pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti‐TNF or conventional therapy: results of the European CONCEIVE study. Alimentary pharmacology & therapeutics, 51(1), 129–138. http://access.bl.uk/ark:/81055/vdc_100132883899.0x00003f